Sorafenib, a systemic therapy for hepatocellular carcinoma
Author:
Publisher
Elsevier BV
Subject
Hepatology,General Medicine
Reference62 articles.
1. Epidemiology of hepatocellular carcinoma;El-Serag;Clin Liver Dis,2001
2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
3. Overexpression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis;Huynh;BMC Gastroenterol,2003
4. BAY 43-9006: preclinical data;Wilhelm;Curr Pharm Des,2002
5. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res,2004
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating cell growth and hypoxic regions of 3D spheroids via a machine learning approach;Machine Learning: Science and Technology;2024-09-01
2. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections;Journal of Cancer Metastasis and Treatment;2024-01-23
3. Thyroid hormone T3 augments the cytotoxicity of sorafenib in Huh7 hepatocellular carcinoma cells by suppressing AKT expression;Journal of Cancer Research and Therapeutics;2023-04-05
4. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma;Biomedicines;2022-12-09
5. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas;International Journal of Molecular Sciences;2021-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3